Liquid Chromatography/Tandem Mass Spectrometry Method for Quantitation of Cremophor EL and Its Applications

被引:4
作者
Bhaskar, V. Vijaya [1 ]
Middha, Anil [1 ]
机构
[1] Jagadishprasad Jhabermal Tibrewala Univ, Dept Pharm, Jhunjhunu 333001, Rajasthan, India
关键词
SOLID-PHASE EXTRACTION; AQUEOUS-SOLUTIONS; PLASMA; FORMULATIONS; PACLITAXEL; BIOFLUIDS; VEHICLE;
D O I
10.1155/2013/135613
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid sensitive and selective MRM based method for the determination of Cremophor EL (CrEL) in rat plasma was developed using liquid chromatography/tandem mass spectrometry (LC-MS/MS). CrEL and polypropylene glycol (internal standard) were extracted from rat plasma with acetonitrile and analysed on C18 column (XBridge, 50 x 4.6 mm, 3.5 mu m). The most abundant molecular ions corresponding to PEG oligomers at m/z 828, 872, 916 and 960 with daughter ion at m/z 89 were selected for multiple reaction monitoring (MRM) in electrospray mode of ionisation. Plasma concentrations of CrEL were quantified after administration through oral and intravenous routes in male sprague dawley rats at a dose of 0.26 g/kg. The standard curve was linear (0.9972) over the concentration range of 1.00 to 200 mu g/mL. The lower limit of quantitation for CrEL was 1.00 mu g/mL using 50 mu L plasma. The coefficient of variation and relative error for inter and intra assay at three QC levels were 0.69 to 9.21 and -7.60 to 4.74 respectively. A novel proposal was conveyed to the scientific community, where formulation excipient can be analysed as qualifier in the analysis of NCEs to address the spiky plasma concentration profiles.
引用
收藏
页数:11
相关论文
共 28 条
  • [21] Detailed molecular characterization of castor oil ethoxylates by liquid chromatography multistage mass spectrometry
    Nasioudis, Andreas
    van Velde, Jan W.
    Heeren, Ron M. A.
    van den Brink, Oscar F.
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2011, 1218 (40) : 7166 - 7172
  • [22] Preclinical formulations for discovery and toxicology: physicochemical challenges
    Neervannan, Seshadri
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (05) : 715 - 731
  • [23] Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassay
    Sparreboom, A
    Loos, WJ
    Verweij, J
    de Vos, AI
    van der Burg, MEL
    Stoter, G
    Nooter, K
    [J]. ANALYTICAL BIOCHEMISTRY, 1998, 255 (02) : 171 - 175
  • [24] Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) in plasma by pre-column derivatization and reversed-phase high-performance liquid chromatography
    Sparreboom, A
    vanTellingen, O
    Huizing, MT
    Nooijen, WJ
    Beijnen, JH
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 681 (02): : 355 - 362
  • [25] Tse F, 1991, PRECLINICAL DRUG DIS
  • [26] WEBSTER LK, 1997, J ONCOL PHARM PRACT, V3, P186
  • [27] WINDEBANK AJ, 1994, J PHARMACOL EXP THER, V268, P1051
  • [28] CREMOPHOR-EL, A WIDELY USED PARENTERAL VEHICLE, IS A POTENT INHIBITOR OF PROTEIN KINASE-C
    ZHAO, FK
    CHUANG, LF
    ISRAEL, M
    CHUANG, RY
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (03) : 1359 - 1367